Aeromics
PrivateLast Round
Strategic
Nov 5, 2019
Total Funding Raised
$10.14M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Aeromics is a pharmaceuticals company that develops anti-edema therapies designed to treat patients affected by acute central nervous system edema.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aeromics Comparables
Compare Aeromics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Remedy Pharmaceuticals | 89% | |
| Egret Therapeutics | 78% | |
| Simcere Pharmaceutical Group | 76% | |
Aeromics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 5, 2019 | ||||
| VC Round | Jun 19, 2018 | ||||
| Series A | Oct 1, 2017 | ||||
| Seed | Apr 6, 2016 | ||||
| Grant | Dec 7, 2009 | ||||
Grant | Sep 15, 2008 |
Aeromics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | VC Round, Series A, Seed |
| NIH RADx | Grant |
| Broadview Ventures | VC Round, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors grew 33% MoM.
- Jun 1, 2025
Monthly visitors increased 72% MoM, reaching 1.4K.
Aeromics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aeromics's valuation, stock price, and market status.